Literature DB >> 2729723

Ivermectin plasma concentrations in collies sensitive to ivermectin-induced toxicosis.

W J Tranquilli1, A J Paul, R L Seward.   

Abstract

Five Collies sensitive to toxic effects of ivermectin and 7 nonsensitive Collies were given 100 micrograms of ivermectin/kg of body weight, PO. Blood samples were collected from each dog before treatment; at posttreatment hours 1, 2, 3.5, 5, and 8; and at posttreatment days 1, 2, 4, 7, 14, and 21. Each sample was assayed for ivermectin concentration, and statistical analyses were performed on the resulting plasma concentration data to determine differences in absorption and clearance of drugs between the 2 groups. Variables measured were area under the curve (using the trapezoidal rule), peak plasma concentration, and the time to peak concentration. Differences between sensitive and nonsensitive Collies for variables analyzed were not significant (P greater than 0.05).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2729723

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  8 in total

1.  Binding characteristics of ivermectin in plasma from collie dogs.

Authors:  S P Rohrer; D V Evans
Journal:  Vet Res Commun       Date:  1990       Impact factor: 2.459

Review 2.  Toxicology of avermectins and milbemycins (macrocylic lactones) and the role of P-glycoprotein in dogs and cats.

Authors:  Valentina M Merola; Paul A Eubig
Journal:  Vet Clin North Am Small Anim Pract       Date:  2012-03       Impact factor: 2.093

Review 3.  A review on the toxicity and non-target effects of macrocyclic lactones in terrestrial and aquatic environments.

Authors:  Jean-Pierre Lumaret; Faiek Errouissi; Kevin Floate; Jörg Römbke; Keith Wardhaugh
Journal:  Curr Pharm Biotechnol       Date:  2012-05       Impact factor: 2.837

Review 4.  Clinical pharmacokinetics in veterinary medicine.

Authors:  J D Baggot
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

5.  Moxidectin toxicity in senescence-accelerated prone and resistant mice.

Authors:  Vanessa K Lee; Asheesh K Tiwary; Prachi Sharma-Reddy; Karen A Lieber; Douglas K Taylor; Deborah M Mook
Journal:  Comp Med       Date:  2009-06       Impact factor: 0.982

Review 6.  Treatment of MDR1 mutant dogs with macrocyclic lactones.

Authors:  Joachim Geyer; Christina Janko
Journal:  Curr Pharm Biotechnol       Date:  2012-05       Impact factor: 2.837

Review 7.  P-glycoprotein mediated drug interactions in animals and humans with cancer.

Authors:  K L Mealey; J Fidel
Journal:  J Vet Intern Med       Date:  2015-01       Impact factor: 3.333

8.  Successful management of ivermectin-induced blindness in an African lion (Panthera leo) by intravenous administration of a lipid emulsion.

Authors:  Muhammad Saqib; Ghazanfar Abbas; Mudassar Niaz Mughal
Journal:  BMC Vet Res       Date:  2015-11-26       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.